ANALYSIS: Ucommune Seeks U.S. Public Investment for Growth Plan

Ucommune aims to raise U.S. growth capital for its ambitious plans to lead the co-working market in China.

ANALYSIS: Muliang Agritech Continues U.S. IPO Effort

Muliang Agritech has filed to raise $56 million in a U.S. IPO, but most of the proceeds will be going to existing shareholders.

ANALYSIS: I-Mab Seeks U.S. IPO for Ambitious Drug Treatment Pipeline

Biopharma firm I-Mab has filed to raise up to $100 million to advance its large drug treatment pipeline. Biopharma firms have continued to raise IPO capital in U.S. markets despite the overall slowdown.

ANALYSIS: Molecular Data Seeks $69 Million U.S. IPO

MKD has grown quickly but its growth rate is decelerating. It operates in a large market to fuel its future growth prospects.

OBSERVATION: What Awaits in 2020 - Watch Out for These Black Swans

Here are the top 20 black swan incidents that are most likely to disrupt global economies and international relations in the new year.

ANALYSIS: Zhongchao Readies Plan for $15 Million U.S. IPO

Zhongchao has proposed terms for its small U.S. IPO. The firm is growing topline revenue at an accelerating rate and the IPO presents a potentially interesting opportunity for a 'risk-on' investor.

ANALYSIS: Genetron Holdings Seeks U.S. IPO Expansion Capital

Genetron Holdings has filed raise growth capital in a U.S. IPO. The firm has grown quickly but that growth is decelerating.

iAsk Su Hua: Is Kuaishou really slowing down? | iAsk Top Leaders